| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8214d26ad73fa6b5da586798f451d3a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee381bc828d34401bc6804e07dac95f5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6949
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D245-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 |
| filingDate |
2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5605dae4e6922006b093ed86d8371d7d |
| publicationDate |
2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8222239-B2 |
| titleOfInvention |
Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
| abstract |
A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, a bridged polycyclic compound may be pharmaceutically active. In some embodiments, a bridged polycyclic compound may be function as a carrier for pharmaceutically active agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9994444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013150809-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9957395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8268381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8766004-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9212286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008020127-A1 |
| priorityDate |
2007-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |